Eastman Chemical Q1 2026 earnings: headline numbers in focus

Eastman Chemical (EMN) has opened 2026 with Q1 revenue of US$2.2b and basic EPS of US$0.94, setting the stage for how investors assess the latest move in profitability. Over recent quarters the company has seen revenue move between US$2.0b and US$2.3b, with basic EPS ranging from US$0.41 to US$2.85, while trailing twelve month EPS sits at US$3.49 on revenue of US$8.6b. With the stock at US$77.53 and trailing net margin at 4.6% versus 9.8% a year earlier, the market is weighing Q1 results through a margin lens and focusing on how earnings growth expectations balance against thinner profitability.

See our full analysis for Eastman Chemical.

With the latest numbers on the table, the next step is to see how this earnings profile lines up with the prevailing narratives around growth potential, risks, and income appeal, and where those stories start to break from the data.

Margins compress as TTM profit falls to US$399m

• Over the last twelve months, Eastman generated about US$8.6b in revenue and US$399m in net income, which works out to a 4.6% net margin compared with 9.8% a year earlier.
• What stands out for the bearish narrative is that margin pressure is already visible in the numbers, while bears still assume some improvement ahead:
  • Bears point to risks like high capital spending and regulatory costs, yet current trailing net income of US$399m is below the US$905m level from twelve months ago, so recent profitability is already closer to their cautious view than to earlier highs.
  • At the same time, bearish assumptions still build in margins rising from 5.4% to 9.0% over three years, which would require a recovery from the current 4.6% trailing margin despite ongoing concerns about tariffs, competition, and environmental costs.

Skeptics warn that compressed margins and heavy spending could keep pressure on profits, but the bearish case still assumes a margin rebuild that is not yet visible in the trailing figures. It helps to see how that view is laid out in detail in the 🐻 Eastman Chemical Bear Case.

Revenue steady near US$2.2b, but EPS swings across recent quarters

• Quarterly revenue has stayed in a fairly tight band between US$2.0b and US$2.3b over the last six reported quarters, while basic EPS has moved from as low as US$0.41 to as high as US$2.85 across the same period.
• For the consensus narrative, that mix of stable top line and uneven EPS ties directly into the idea of earnings normalization:
  • Analysts expect earnings to reach US$904.5m by around 2028, up from US$832.0m in their base today, even though the latest trailing twelve month net income is US$399m, so the current run rate sits well below the medium term path they are using.
  • Consensus also assumes profit margins edging up from 9.0% to 9.5% over three years, yet the latest trailing margin is 4.6%. Any move toward their margin band would first need a sizeable step up from where the company is operating now.

Valuation signals and 4.33% dividend tested against bullish case

• At a share price of US$77.53, Eastman trades on a trailing P/E of 22.2x, below the peer average of 33.6x and industry average of 26.8x, and sits well under the DCF fair value of about US$134.66, while also offering a 4.33% dividend yield.
• These datapoints line up closely with what bullish investors focus on, but the earnings base they rely on is very different from the last twelve months:
  • Bullish views look for earnings to reach about US$964m and EPS of US$8.41 by around 2029, compared with US$474m of earnings used in their starting point and US$399m from the latest trailing twelve month data, so the current level is still some distance from both reference points.
  • Bulls also work off a DCF framework that supports higher value. While the DCF fair value of US$134.66 is above the current price of US$77.53, the gap needs to be weighed against the fact that trailing margins have moved from 9.8% to 4.6% over the last year.

Bulls argue that stronger earnings growth and recycling projects can close the gap between today’s 4.6% margin and their higher profit expectations, so it is worth seeing exactly how that upside thesis connects back to the latest numbers in the 🐂 Eastman Chemical Bull Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Eastman Chemical on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

The mix of pressure on margins and optimism about future earnings can feel pulled in two directions. It makes sense to look closely at the details and decide where you stand, using our breakdown of 4 key rewards and 2 important warning signs

See What Else Is Out There

Eastman Chemical is wrestling with compressed margins, uneven EPS and a P/E of 22.2x that still leans on earnings well below bullish and consensus narratives.

If those pressures on profitability and valuation make you cautious, it is worth scanning for companies with steadier earnings and more comfortable pricing using the 67 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.